Status:
TERMINATED
APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Société Nationale Française de Gastroentérologie
Ministry of Health, France
Conditions:
Colon Adenomas
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Experimental and epidemiologic studies have suggested that aspirin intake reduces the risk for colorectal cancer. In the APACC study we randomly assigned 291 patients to daily Aspirin or Placebo for 4...
Detailed Description
The APACC Study is a prospected, randomized, double-blind, placebo-controlled multicentre clinical trial design to test the efficacy of regular low-dose aspirin administration in reducing the recurren...
Eligibility Criteria
Inclusion
- Patients are aged between 18 and 75 years At least 3 adenomas irrespective size or at least one measuring 6mm or more All subjects had a clean colon at the study entry
Exclusion
- No personal history of colon cancer, no inflammatory bowel disease, no familial adenomatous polyposis, no regular use of aspirin
Key Trial Info
Start Date :
March 1 1997
Trial Type :
INTERVENTIONAL
End Date :
March 1 1999
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00224679
Start Date
March 1 1997
End Date
March 1 1999
Last Update
June 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital COCHIN Service d'Hépato-Gastro-Entérologie
Paris, Île-de-France Region, France, 75014